2-minute questionnaire
Tell us about your weight history, prior GLP-1 use, BMI, and related conditions like type 2 diabetes or obstructive sleep apnea.
Zepbound (tirzepatide) hits both GIP and GLP-1 receptors, the dual mechanism behind the largest weight loss of any FDA-approved medication. Pick the vial, KwikPen, or single-dose pen. Prescription, titration, and physician follow-up included.

No clinic visits. A licensed physician picks the right form and starting dose, manages every titration step, and routes you to the most affordable supply.
Tell us about your weight history, prior GLP-1 use, BMI, and related conditions like type 2 diabetes or obstructive sleep apnea.
A licensed physician confirms eligibility, picks vial, KwikPen, or single-dose pen, and writes your starting prescription, usually within 1 business day.
We verify insurance and file prior authorization. If self-pay makes more sense, we shop your dose across manufacturer-direct and pharmacy options for whichever form you prefer (vial, KwikPen, or single-dose pen) and show you the lowest monthly cost before you commit.
Start at 2.5mg weekly and step up every 4 weeks toward your maintenance dose. We monitor side effects, manage refills, and time each dose increase with you.
Two line items: Instalab Membership and the Zepbound medication itself, billed by the pharmacy or by Lilly directly. No hidden fees.
Physician oversight, titration management, and ongoing follow-up
Tirzepatide injection, billed by pharmacy
Why pay a membership fee? Zepbound needs a physician who actively manages titration, side effects, and form selection across six dose strengths. Membership covers the visits, renewals, prior authorization, and shopping your dose across manufacturer-direct and pharmacy options so you land on the cheapest source for the form you want. Labs to track metabolic health are billed separately.
Some commercial plans cover Zepbound for chronic weight management or moderate-to-severe obstructive sleep apnea with obesity. Coverage depends on your plan's obesity and OSA benefits, BMI, and documented weight-related conditions. We check your plan and file the prior authorization either way. If insurance won't cover it, we shop self-pay options across manufacturer-direct and pharmacy channels for whichever form you prefer.
It needs a physician who manages dose increases, side effects, and metabolic monitoring across six dose steps. Here's how our team handles that for you.
A licensed physician reviews your weight history, BMI, related conditions, and goals, then writes your starting prescription at 2.5mg. In parallel, we verify your insurance and, if you prefer to skip it, shop self-pay options across manufacturer-direct and pharmacy channels to find the cheapest source for your preferred form.
Your Zepbound vial, KwikPen, or single-dose pen ships from the pharmacy. We walk you through self-injection and check in after your first dose.
Step up by 2.5mg every 4 weeks if tolerated, toward a maintenance dose of 5, 10, or 15mg. We coordinate each refill with the new dose so you never run short.
Your physician tracks weight, side effects, and metabolic labs over time, and adjusts the plan as you progress. We keep your prescription, prior authorization, and pharmacy on the same page so you don't lose months to paperwork.
Schedule a PCP visit. Wait months. Hope they know how to titrate. Chase prior auth and manufacturer paperwork yourself. Manage side effects between appointments.
2-minute questionnaire. Physician review within 1 business day. Insurance and manufacturer-direct supply handled. Titration and side-effect check-ins built in.
Zepbound comes as a vial, a KwikPen, or a single-dose pen. Same medicine, three formats — pick the one that fits your routine and budget. All three are subcutaneous injections once a week, into the thigh, stomach, or upper arm.
Older weight-loss medications activate a single receptor. Tirzepatide activates both GIP and GLP-1, the two main incretin pathways that regulate appetite, insulin response, and gastric emptying. In its pivotal trial, that dual mechanism produced the largest sustained weight loss of any FDA-approved medication.
Published in NEJM in 2022, SURMOUNT-1 randomized 2,539 adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with weight-related conditions, without diabetes, to tirzepatide 5mg, 10mg, 15mg, or placebo, alongside diet and exercise. At 72 weeks, the 15mg group lost a mean 20.9% of body weight versus 3.1% on placebo. A separate program, SURMOUNT-OSA, supported FDA approval for moderate-to-severe obstructive sleep apnea in adults with obesity.
Three patients, 16 to 36 weeks in.
“I'd tried every diet for a decade. Six months in and I'm down almost 40 pounds without thinking about food constantly.”
“My insurance dropped GLP-1 coverage. Instalab found a self-pay source for the vials in a day and the titration plan kept the nausea manageable.”
“My sleep study showed moderate apnea. Insurance covered the single-dose pen, and my CPAP pressure has come down with the weight loss.”
Zepbound is a prescription medicine. Important safety information applies. The most common side effects are nausea, diarrhea, vomiting, and constipation, usually mild and most common during dose increases. Serious side effects are uncommon.
Answer a few questions about your weight history, BMI, and goals. A physician reviews your case, picks the right form and starting dose, and, if appropriate, prescribes Zepbound. We handle titration, refills, and follow-up from there.
No commitment to treatment.